MOH: Expert Committee On Covid-19 Vaccination's Assessment On Myocarditis and Pericarditis Following Mrna Covid-19 Vaccination

jonesftw

High Supremacy Member
Joined
Jul 12, 2010
Messages
30,843
Reaction score
1,199
The Expert Committee has been closely monitoring international reports that the second dose of mRNA COVID-19 vaccines may be associated with a small risk of myocarditis and pericarditis in young men. We have reviewed the currently available international and local data. Our assessment is that the benefits of receiving the mRNA COVID-19 vaccines, i.e., reduction in COVID-19 infections and severe complications even if infected, continue to outweigh the risks of vaccination.

Myocarditis and Pericarditis with mRNA Vaccines

2. Myocarditis and pericarditis are inflammatory conditions affecting the heart muscles and the outer lining of the heart respectively. They occur more often in men compared to women. Patients present with symptoms such as chest pain, shortness of breath or abnormal heartbeats. Most cases are mild, recover without the need for significant intervention and do not suffer any long-term effects, although very rarely, severe cases may result in damage to the heart muscles. Myocarditis and pericarditis are separate and distinct conditions from heart attacks which are caused when blood flow to the heart is blocked.

3. Increased occurrences of myocarditis and pericarditis after the second dose of mRNA COVID-19 vaccinations have been observed overseas (Israel and the United States [US]) in adolescents and young men below the age of 25 years. The risk of this has been estimated to be 1.6 cases per 100,000 doses for mRNA vaccines in the US, which is comparable to the risk of anaphylaxis observed in Singapore. To date, there is no observed incremental risk of myocarditis and pericarditis after the first dose of vaccine.

4. Locally, the Health Sciences Authority (HSA) has reported 4 cases involving young men aged between 18 to 30 years. This is at the upper end of the expected range for this age group, based on background incidence rates. Most of the cases were reported to have occurred within a few days after receiving the second dose of the vaccine. All have recovered or have been discharged well from hospital.

Recommendations

5. While further studies and investigations are on-going, the currently available data suggests that there may be a very small risk of myocarditis and pericarditis after the second dose of an mRNA vaccine, particularly in young men. As a precaution, EC19V recommends that vaccinated persons, in particular adolescents and younger men, should avoid strenuous physical activity for one week after their second dose. During this time, they should seek medical attention promptly if they develop chest pain, shortness of breath or abnormal heartbeats.

6. COVID-19 continues to be a health threat globally and in Singapore. The emergence of infectious variants can lead to widespread community COVID-19 transmission as well as the risk of severe COVID-19 disease and complications, including long term chronic complications. EC19V assesses that the benefits of the mRNA COVID-19 vaccinations continue to outweigh the known and potential risks.

7. EC19V will continue to monitor the available data as further analyses are conducted locally and internationally and will provide an update to the public.

 

week3nd

Member
Joined
May 21, 2021
Messages
106
Reaction score
32
It is good that they acknowledged it. So if kena any similar condition can claim from the vaccine injury programme or not?
 

desmond_yee1

Arch-Supremacy Member
Joined
Feb 7, 2021
Messages
12,834
Reaction score
4,059
The Expert Committee has been closely monitoring international reports that the second dose of mRNA COVID-19 vaccines may be associated with a small risk of myocarditis and pericarditis in young men. We have reviewed the currently available international and local data. Our assessment is that the benefits of receiving the mRNA COVID-19 vaccines, i.e., reduction in COVID-19 infections and severe complications even if infected, continue to outweigh the risks of vaccination.

Myocarditis and Pericarditis with mRNA Vaccines

2. Myocarditis and pericarditis are inflammatory conditions affecting the heart muscles and the outer lining of the heart respectively. They occur more often in men compared to women. Patients present with symptoms such as chest pain, shortness of breath or abnormal heartbeats. Most cases are mild, recover without the need for significant intervention and do not suffer any long-term effects, although very rarely, severe cases may result in damage to the heart muscles. Myocarditis and pericarditis are separate and distinct conditions from heart attacks which are caused when blood flow to the heart is blocked.

3. Increased occurrences of myocarditis and pericarditis after the second dose of mRNA COVID-19 vaccinations have been observed overseas (Israel and the United States [US]) in adolescents and young men below the age of 25 years. The risk of this has been estimated to be 1.6 cases per 100,000 doses for mRNA vaccines in the US, which is comparable to the risk of anaphylaxis observed in Singapore. To date, there is no observed incremental risk of myocarditis and pericarditis after the first dose of vaccine.

4. Locally, the Health Sciences Authority (HSA) has reported 4 cases involving young men aged between 18 to 30 years. This is at the upper end of the expected range for this age group, based on background incidence rates. Most of the cases were reported to have occurred within a few days after receiving the second dose of the vaccine. All have recovered or have been discharged well from hospital.

Recommendations

5. While further studies and investigations are on-going, the currently available data suggests that there may be a very small risk of myocarditis and pericarditis after the second dose of an mRNA vaccine, particularly in young men. As a precaution, EC19V recommends that vaccinated persons, in particular adolescents and younger men, should avoid strenuous physical activity for one week after their second dose. During this time, they should seek medical attention promptly if they develop chest pain, shortness of breath or abnormal heartbeats.

6. COVID-19 continues to be a health threat globally and in Singapore. The emergence of infectious variants can lead to widespread community COVID-19 transmission as well as the risk of severe COVID-19 disease and complications, including long term chronic complications. EC19V assesses that the benefits of the mRNA COVID-19 vaccinations continue to outweigh the known and potential risks.


7. EC19V will continue to monitor the available data as further analyses are conducted locally and internationally and will provide an update to the public.

so later if got serious side effects how? since covid serious symptoms are very low for young people, the reasonable thing is suspend vaccination for this group.
 

rachdanon

Supremacy Member
Joined
Mar 19, 2007
Messages
6,117
Reaction score
123
benefits outweigh risks ....really? for a country with the lowest risk of getting Covid....tell me that in India and I will believe.
 

Krabs.

Honorary Member
Joined
May 8, 2007
Messages
118,015
Reaction score
331
i thinking of buying some vitamin c to eat before and after .......
 

desmond_yee1

Arch-Supremacy Member
Joined
Feb 7, 2021
Messages
12,834
Reaction score
4,059
benefits outweigh risks ....really? for a country with the lowest risk of getting Covid....tell me that in India and I will believe.
PAP will take the benefits by opening up while any risks you bear yourself
 

sizzy6

Arch-Supremacy Member
Joined
Nov 20, 2006
Messages
15,142
Reaction score
621
The Expert Committee has been closely monitoring international reports that the second dose of mRNA COVID-19 vaccines may be associated with a small risk of myocarditis and pericarditis in young men. We have reviewed the currently available international and local data. Our assessment is that the benefits of receiving the mRNA COVID-19 vaccines, i.e., reduction in COVID-19 infections and severe complications even if infected, continue to outweigh the risks of vaccination.

Myocarditis and Pericarditis with mRNA Vaccines

2. Myocarditis and pericarditis are inflammatory conditions affecting the heart muscles and the outer lining of the heart respectively. They occur more often in men compared to women. Patients present with symptoms such as chest pain, shortness of breath or abnormal heartbeats. Most cases are mild, recover without the need for significant intervention and do not suffer any long-term effects, although very rarely, severe cases may result in damage to the heart muscles. Myocarditis and pericarditis are separate and distinct conditions from heart attacks which are caused when blood flow to the heart is blocked.

3. Increased occurrences of myocarditis and pericarditis after the second dose of mRNA COVID-19 vaccinations have been observed overseas (Israel and the United States [US]) in adolescents and young men below the age of 25 years. The risk of this has been estimated to be 1.6 cases per 100,000 doses for mRNA vaccines in the US, which is comparable to the risk of anaphylaxis observed in Singapore. To date, there is no observed incremental risk of myocarditis and pericarditis after the first dose of vaccine.

4. Locally, the Health Sciences Authority (HSA) has reported 4 cases involving young men aged between 18 to 30 years. This is at the upper end of the expected range for this age group, based on background incidence rates. Most of the cases were reported to have occurred within a few days after receiving the second dose of the vaccine. All have recovered or have been discharged well from hospital.

Recommendations

5. While further studies and investigations are on-going, the currently available data suggests that there may be a very small risk of myocarditis and pericarditis after the second dose of an mRNA vaccine, particularly in young men. As a precaution, EC19V recommends that vaccinated persons, in particular adolescents and younger men, should avoid strenuous physical activity for one week after their second dose. During this time, they should seek medical attention promptly if they develop chest pain, shortness of breath or abnormal heartbeats.

6. COVID-19 continues to be a health threat globally and in Singapore. The emergence of infectious variants can lead to widespread community COVID-19 transmission as well as the risk of severe COVID-19 disease and complications, including long term chronic complications. EC19V assesses that the benefits of the mRNA COVID-19 vaccinations continue to outweigh the known and potential risks.

7. EC19V will continue to monitor the available data as further analyses are conducted locally and internationally and will provide an update to the public.

so now got VAR liao can apply it retroactively and compensate those who mati due to heart attack?
 

iammole

High Supremacy Member
Joined
Apr 17, 2007
Messages
30,823
Reaction score
381
wondering what would be the take-up rate for booster jab when these kinda news are out.
 

kimsix

Supremacy Member
Joined
Jan 6, 2009
Messages
6,875
Reaction score
368

A detailed analysis at Hadassah Medical Center, a major hospital serving the greater Jerusalem area, found that cases of myocarditis at the facility were five to 25 times the normal number over the same time span in previous years, Dror Mevorach, the head of internal medicine and the COVID-19 ward at Hadassah, told Intelligencer. This potentially puts the rate as high as one in 3,000 to one in 6,000 vaccinated young men, he said. Mevorach, who also headed the national committee to investigate the myocarditis link, said that over a span of three months the hospital saw 20 cases of myocarditis, when it typically sees only four; 19 of the 20 cases were young males, ages 16 to 30. Eighteen of the 20 cases presented within four days of the second vaccine dose. The patients all had chest pain or difficulty breathing, ruling out that the condition was asymptomatic and caught inadvertently by general tests, Mevorach said. Only two patients of the 20 had evidence of past infection, eliminating any correlation with COVID-19 itself, rather than the vaccine.
 

Senna Wales

Great Supremacy Member
Joined
May 17, 2011
Messages
67,622
Reaction score
781
benefits outweigh risks ....really? for a country with the lowest risk of getting Covid....tell me that in India and I will believe.
They're lying for the sake of padding statistics of numbers and percentage vaccinated. Benefits for vaccinating the young are low, because (able to be proven statistically) they have very low risk of symptoms, and high risk of complications. They are safe for however long it takes for the next gen vaccines to show up.
 
Important Forum Advisory Note
This forum is moderated by volunteer moderators who will react only to members' feedback on posts. Moderators are not employees or representatives of HWZ. Forum members and moderators are responsible for their own posts.

Please refer to our Terms of Service for more information.
Top